These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10294666)

  • 21. Hospitals defend formulary decisions against industry attacks.
    Talley CR
    Am J Hosp Pharm; 1978 Sep; 35(9):1154-5. PubMed ID: 696756
    [No Abstract]   [Full Text] [Related]  

  • 22. Rational formulary selection of antimicrobials.
    DiPiro JT; Steele JC
    Am J Hosp Pharm; 1987 Jan; 44(1):74. PubMed ID: 3826091
    [No Abstract]   [Full Text] [Related]  

  • 23. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms.
    Bosso JA; Mauldin PD; Steed LL
    Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay.
    Kuster SP; Ruef C; Zbinden R; Gottschalk J; Ledergerber B; Neuber L; Weber R
    J Antimicrob Chemother; 2008 Dec; 62(6):1451-61. PubMed ID: 18776189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug formulary decision-making in two regional health authorities in British Columbia, Canada.
    Armstrong K; Mitton C; Carleton B; Shoveller J
    Health Policy; 2008 Dec; 88(2-3):308-16. PubMed ID: 18508151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of hospital formularies on fluoroquinolone prescribing in emergency departments.
    Aspinall SL; Metlay JP; Maselli JH; Gonzales R
    Am J Manag Care; 2007 May; 13(5):241-8. PubMed ID: 17488189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The P&T committee: Clinical Hospital Center, Zagreb, Yugoslavia.
    Vrhovac B; Francetic I
    Hosp Formul; 1984 Dec; 19(12):1158-9, 1162. PubMed ID: 10269439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Resistance of bacteria and antibiotic prescription in Fann University Teaching Hospital, Dakar].
    Sow AI; Boye A; Ka Sall R; Ndour CT; Soumare M; Seydi M; Samb A
    Dakar Med; 2003; 48(3):189-93. PubMed ID: 15776629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P & T Committee interview: Establishing and maintaining a dynamic formulary.
    Rostand S; Lazarus H
    Hosp Formul; 1988 Jan; 23(1):48-53. PubMed ID: 10285373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The formulary system: product of the teaching hospital.
    Francke DE
    Hospitals; 1967 Nov; 41(22):110 passim. PubMed ID: 6062395
    [No Abstract]   [Full Text] [Related]  

  • 32. Improvement in antibiotic use secondary to a small hospital antibiotic review.
    Strahl DA; Wightkin WT
    Hosp Formul; 1985 Mar; 20(3):310-2. PubMed ID: 10270306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective decision-making in a changing healthcare environment: a P & T Committee interview.
    Zoloth A; Yon JL; Woolf R
    Hosp Formul; 1989 Feb; 24(2):85-7, 90, 93 passim. PubMed ID: 10291815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P & T Committee role in advocating rational therapeutics.
    Borreson R
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does your committee pass the McNemar test?
    Owen JA
    Hosp Formul; 1979 Jun; 14(6):605. PubMed ID: 10242200
    [No Abstract]   [Full Text] [Related]  

  • 36. The Alexander Project: the benefits from a decade of surveillance.
    Felmingham D; White AR; Jacobs MR; Appelbaum PC; Poupard J; Miller LA; Grüneberg RN
    J Antimicrob Chemother; 2005 Oct; 56 Suppl 2():ii3-ii21. PubMed ID: 16282278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formulary system controversies in the new environment of DRGs.
    Lipman AG
    Hosp Formul; 1985 Feb; 20(2):218, 221-4, 229 passim. PubMed ID: 10311021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparing the P & T committee agenda for new drug requests.
    Standish RC; Evans PJ; Bell JE
    Hosp Formul; 1984 Sep; 19(9):792, 795-800. PubMed ID: 10267929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P & T committees and the hospital formulary.
    Evans PJ; Standish RC; Bell JE
    Hosp Formul; 1983 Sep; 18(9):892-5. PubMed ID: 10262367
    [No Abstract]   [Full Text] [Related]  

  • 40. Appropriate antibiotic therapy for community-acquired respiratory tract infections.
    Gerbino PP; Brixner D; Sbarbaro J; Nicolau D
    Manag Care Interface; 2005 Dec; 18(12):41-8. PubMed ID: 16405224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.